lxrβ agonist-2

LXRβ agonist-2 is a highly potent and β-selective liver X receptor (LXRβ) agonist with an EC50 of 7 nM.

LXR agonist 2 is a potent agonist of the LXR (liver X receptor). LXR agonist 2 stabilises NCOA1 (coactivator), which in turn agonises the LXR.

Ginsenoside C-K hexapropionate ester (Structure 2) acts as a selective agonist for LXRα without significantly activating LXRβ. By stimulating LXRα, it enhances the expression of downstream genes such as ABCA1, facilitating reverse cholesterol transport and reducing lipid accumulation in macrophage-derived foam cells, making it useful for atherosclerosis research. This compound is a synthetic derivative, created by modifying the active metabolite of Panax notoginseng saponins, Ginsenoside Compound K, with propionic anhydride.

LXR antagonist 2 (compound 10rr) is a potent LXR (liver X receptor) inverse agonist, targeting LXRβ (IC50: 0.36 μM) and LXRα (IC50: 2.25 μM). It serves as an adipogenesis inhibitor, downregulating LXR target genes SREBP-1c, ACC, FAS, and SCD-1, and demonstrates hypolipidemic activity in Triton WR-1339-induced hyperlipidemic mice.

AZ-2 is an inducer of ABCA1 and apoE. It enhances ABCA1 activity and decreases P2X7 receptor activity. AZ-2 activates endogenous LXR signaling but shows no direct LXRα or LXRβ agonist activity.

TUG-1375 is an Agonist of Thiazolidine Free Fatty Acid Receptor 2